Read the First Edition of The Lens, a new magazine by LSI
Published January 2009 | Forecasts through 2013
Worldwide Markets and Emerging Technologies for Tissue Engineering and Regenerative Medicine
image
Overview
The tissue engineering and regenerative medicine market first emerged in the mid-1990's with the introduction of products for wound care and orthopaedic applications. The market has since expanded substantially, and approached $1.5 billion in 2008. The market is projected to grow at a 16.2% compound annual rate from 2008 through 2013, approaching $3.2 billion by 2013. This in-depth new market and technology report analyzes the following key topics:
  • Tissue engineering and regenerative medicine technologies
  • Market analysis for cardiovascular applications of tissue engineering and regenerative medicine, including heart valve repair and replacement, myocardial tissue regeneration for heart failure, and applications in peripheral vascular and coronary artery disease
  • Orthopaedic applications and market analysis, including cartilage repair and replacement, bone repair, ligament and tendon repair and replacement, joint repair, and spinal disc repair
  • Applications in neurology including repair of spinal cord injury, Parkinson's disease, epilepsy, multiple sclerosis, peripheral nerve injury, stroke and CNS disorders
  • Market analysis for applications in urology including treatment of urinary incontinence, bladder repair, ureter and urethra repair, penile reconstruction and treatment of erectile dysfunction, and treatment of vesicoureteral reflux
  • Applications in organ regeneration including analysis of existing organ supplementation markets and technologies and development-stage technologies for liver, kidney, heart, pancreas, bone marrow, and small intestine replacement
  • Market analysis for applications in wound management, skin repair, and skin ulcer treatment
  • Current and forecast market size, pricing trends, and analysis of competitive factors
  • Key business transactions, competitor strategies, and technology portfolio analysis
  • Detailed coverage of 227 companies plus in-depth competitor profiles of top 40
Buy Neurovascular Devices for
Hemorrhagic Stroke Market Snapshot
Companies Covered
3H Biomedical
Aastrom Biosciences
AbioMed
ACell
Advanced BioHealing
Advanced Cell Technology
Aesculap/B. Braun
Agera Laboratories
Aldagen
American Medical Systems
Amgen
Amorcyte
AMS Medical Solutions
Angel Biotechnology
AnGes MG
Angioblast Systems
Anthrogenesis
Applikon Biotechnology
Arteriocyte
Arthrokinetics
Athersys
Atrium Medical
BabyTooth Technologies
Bard Peripheral Vascular
Baxter Healthcare
Bayer Schering Pharma
Berkeley Advanced Biomaterials
Berlin Heart
BioCancell Therapeutics
BioEden
Biofisica
Biogen
Bioheart
BioMimetic Therapeutics
BioSyntech
Bioteck
BioTransplant
Boston Scientific
Bristol Myerers Squibb
Carbon Medical Technologies
Capricor
Cardio3 BioSciences
Cardium Therapeutics
CBR Systems
Cellerant Therapeutics
Cellerix
Cell Genesys
Cells for Life
Celltran
Cellulogix International
Celprogen
Cerapedics
CJ CheilDejang
CoAxia
Co.don
Coloplast
Cook Group/Cook Biotech
CorCell/Cord Blood America
Cordis
CORD:USE
CordPartners (CorCell)
Concentric Medical
Cousin Biotech
Covidien
C.R. Bard
CrossCart
Cryobanks International
CryoCell International
CryoCord
CryoLife
Cryo-Save Group
Curative Biosciences
Curis
Cyberkinetics Neurotechnology Systems
Cyberonics
Cytograft Tissue Engineering
Cytori Therapeutics
DePuy Orthopaedics
DomaniCell
Edwards Lifesciences
Elan Pharmaceuticals
Eli Lilly
Eisai Pharmaceuticals
ES Cell International
Ethicon
Fenwal
Fidia Farmaceuticis
Forest Pharmaceuticals
Forticell Bioscience
Fresenius Medical Care
Future Health Technologies
Gambro
Gamida Cell
GeneGrafts
Geistlich Pharma
GenVec
Genzyme
Geron Corporation
GlaxoSmithKline
Glen Mills
Glycosan BioSystems
Harvet Technologies
Healthcord Cryogenics
Haemonetics
Healthpoint
HemaCare
Histogenics
Hospira
Humacyte
ICOS Therapeutics
Insception Biosciences
Integra LifeSciences
International Stem Cell
Isolagen
ISTO Technologies
ITxM Cord Blood Services
Jarvik Heart
JCR Pharmaceuticals
Jecoli
J&J Gynecare
J&J Mitek
J&J Regenerative
J.P. McCarthy Cord Stem Cell Bank
Kensey Nash
Kinetic Concepts
LifebankUSA
LifeCell
LifeCord
LifeLine Cord Blood Bank
Macropore Biosurgery
Matricel
MAZE Labs
Medical Device Alliance/Arthrocare
Medisorb Technologies
Medtronic
Mesoblast
MicroIslet
MicroMed Cardiovascular
Mirus Bio
Miltenyi Biotech
MultiCell Technologies
MultiGene Vascular Systems
Musculoskeletal Transplant Foundation
Mylan Bertek Pharmaceuticals
Neomedic
New Brunswick Scientific
Neuralstem
NeuroMetrix
Neuronyx
Neurotech
Newborn Blood Banking
NMT Medical
Novartis
NovaThera/MedCell Bioscience
Novocell
NuVasive
Olympus
OrbusNeich
Organogenesis
Ormed
Orthofix
Orthogen
Ortho-McNeil
Orthopeutics
Osiris Therapeutics
Osteopore International
Osteotech
Pegasus Biologics
Pervasis Therapeutics
Pfizer
Pioneer Surgical
Plureon
Pluristem Therapeutics
Progenitor Cell Therapy
Promedon
Protein Polymer Technologies
Q Therapeutics
ReGen Biologics
Regenerative Sciences
ReGenLab
RenaMedical Biologics
ReNeuron Group
SaluMedica
Saneron CCEL Therapeutics
Sanofi Aventis
Sartorius
Sciele Pharma
Scil Technology
SecuraCell
Sewon Cellontech
Smith & Nephew
Stem Cell Innovations
StemCells
StemCell Technologies
StemCell Therapy International
StemCor Systems
StemCyte International
Stemedica Cell Technologies
Stem Sciences Cord Blood Bank
StemTech International
St. Jude Medical
Stryker
SynCardia Systems
Symetis
Tengion
Tepha
TETEC Tissue Engineering Technologies
Teva Pharmaceutical
Theradigm
Therics
Thoratec
TiGenix
Tissue Repair Company
Titan Pharmaceuticals
Uromedica
Uroplasty
ViaCord
ViCal
W.L. Gore & Associates
World Heart
Wyeth
XMEDICA
Zellwerk
Zen-bio
Zimmer

Order individually or subscribe and
get a complete intel platform.

Trusted By The Companies Pioneering What’s Next